TitleCareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent KitsProduct Service Code: 6550NAICS Code: 541714Place of Performance:Bethesda, MD 20892 USAPOTS: 26–000014DescriptionThis is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.The National Institutes of Health (NIH) plans to issue a firm fixed–price purchase order to CareDx Lab Solutions Inc. located in West Chester, Pennsylvania, 19382, on a sole source basis. This order is for Next Generation Sequencing (NGS) reagent kits needed by the Department of Transfusion Medicine.The purpose of this acquisition is for the National Institutes of Health (NIH) Human Leukocyte Antigen (HLA) Laboratory to secure a one–year supply of Next Generation Sequencing (NGS) reagents from CareDx Lab Solutions Inc. Shipments are planned for, February 2026, May 2026, and August 2026. These quarterly deliveries will ensure the HLA Lab maintains adequate stock for patient testing. The contract`s performance period will run from January 16,2026 to September 30, 2026.The NIH is the leading federally funded biomedical research institution in the United States, comprising twenty–seven Institutes and Centers. The NIH Clinical Center (CC), located on the NIH campus, serves as the onsite hospital, fully supporting clinical studies in both inpatient and outpatient settings. The NIH CC is an 870,000 square–foot facility equipped to accommodate 240 inpatient beds and 82 day–hospital stations.The Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine at the Clinical Center has several key functions:To provide clinical diagnostic laboratory testing for patients at the Clinical Center, aiding in potential transplant eligibility or enrollment in relevant protocols for their specific conditions.To offer clinical consultations to Clinical Center physicians regarding patient management in potential transplant scen